Sunshine Biopharma Inc. warrant closed at $0.05 on Sep 18, up 74.19%, 84.4% below its highest close since Feb 15. Volume of 2.0K shares was 0.43× its 20-day average (below normal).
Split-adjusted performance: +33.5% over one month, -61.4% over six months.
In the quarter ended Jun 30, 2026, revenue was $9.26M, down 1.6% from a year earlier, with a net margin of -16.9%.
Short interest was 773 shares at the Sep 15 settlement (20.3 days to cover).
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements.
What is SBFMW's market cap?
$165.38K, based on the Sep 18 close of $0.05.
What sector is SBFMW in?
Healthcare, in the Pharmaceuticals industry.
About Sunshine Biopharma Inc. warrant
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
